| Bioactivity | FAAH-IN-1 is a fatty acid amide hydrolase (FAAH) inhibitor, with IC50s of 145 nM and 650 nM for rat and human FAAH, respectively. |
| Target | IC50: 145 nM (Rat FAAH), 650 nM (Human FAAH) |
| Invitro | FAAH-IN-1 (Compound 8) is a fatty acid amide hydrolase (FAAH) inhibitor, with IC50s of 145 nM and 650 nM for rat and human FAAH, respectively[1]. |
| Name | FAAH-IN-1 |
| CAS | 1242441-47-9 |
| Formula | C20H19ClN4OS |
| Molar Mass | 398.91 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Liu P, et al. Discovery of MK-3168: A PET Tracer for Imaging Brain Fatty Acid Amide Hydrolase. ACS Med Chem Lett. 2013 Apr 20;4(6):509-13. |
FAAH-IN-1
CAS: 1242441-47-9 F: C20H19ClN4OS W: 398.91
FAAH-IN-1 is a fatty acid amide hydrolase (FAAH) inhibitor, with IC50s of 145 nM and 650 nM for rat and human FAAH, resp
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.